Future Science Group Catalogue 2019

Total Page:16

File Type:pdf, Size:1020Kb

Future Science Group Catalogue 2019 Header Future Science Group Catalogue 2019 Contact us Future Science Group Unitec House 2 Albert Place London, N3 1QB United kingdom +44(0)20 8371 6090 [email protected] [email protected] www.future-science-group.com @futuresciencegp future-science-group Future Science Group 1 Section Header 2 For more information visit www.future-science-group.com Contents Page Our Journal Portfolio 2 ........................................................................................................................................ Future Medicine At-A-Glance 3 ........................................................................................................................................ Future Science and Newlands Press At-A-Glance 4 ........................................................................................................................................ eBook Collections 4 ........................................................................................................................................ New to Future Science 5 ........................................................................................................................................ Information for Librarians 6 ........................................................................................................................................ Institutional Trials 7 ........................................................................................................................................ Digital Hubs 8 ........................................................................................................................................ Sponsorship Opportunities 9 ........................................................................................................................................ Testimonials 9 ........................................................................................................................................ 1 Our Journal Portfolio Our Journal Portfolio Future Science Group (FSG) is an independent publisher, based in London, with an expanding and diverse group of journals in cutting-edge areas of postgenomic scientific and medical information. FSG houses three imprints; Future Medicine, Future Science and Newlands Press. All journals are peer reviewed and many are also indexed on MEDLINE, Clarivate’s Science Citation Index Expanded and Emerging Sources Citation Index, EMBASE, Chemical Abstracts, DOAJ, PubMed Central and Scopus. We also offer DRM-free perpetual access to a wide variety of eBook collections. ALL PUBLICATIONS ARE: ORIGINAL AND TIMELY Blending commissioned and unsolicited content, including reviews, research and commentaries, to ensure that readers are kept comprehensively up-to-date with the latest advances and techniques in bioscience and clinical practice, whatever their discipline. SUPPORTED BY STRONG EDITORIAL STANDARDS All journals are underpinned by robust double-blind peer review ensuring only articles of the highest quality are published. Authors benefit from a supportive in-house editorial team, taking them from pre-submission enquiries, right through to publication and beyond. VISIBLE AND ACCESSIBLE GLOBALLY To ensure 24/7 access and maximum discoverability, all of our titles are hosted by Atypon on industry-leading websites. 2 For more information visit www.future-science-group.com Future Medicine At-A-Glance FUTURE MEDICINE AT-A-GLANCE Journal MEDLINE- Impact factor Frequency Launch indexed (2017) year Open access journals Breast Cancer Management No n/a Rolling 2012 CNS Oncology Yes n/a Rolling 2012 Colorectal Cancer No n/a Rolling 2012 Concussion PMC-indexed n/a Rolling 2015 Future Neurology No n/a Rolling 2006 Hepatic Oncology PMC-indexed n/a Rolling 2014 International Journal of Endocrine Oncology No n/a Rolling 2014 International Journal of Hematologic Oncology PMC-indexed n/a Rolling 2012 Lung Cancer Management No n/a Rolling 2012 Melanoma Management PMC-indexed n/a Rolling 2014 Journals Bioelectronics in Medicine No n/a 4 2018 Biomarkers in Medicine Yes 2.346 18 2007 Epigenomics Yes 4.979 16 2009 Future Cardiology Yes n/a 6 2005 Future Microbiology Yes 3.190 18 2006 Future Oncology Yes 2.369 36 2005 Future Virology No 1.121 12 2006 Immunotherapy Yes 3.461 18 2009 Journal of 3D Printing in Medicine No n/a 4 2017 Journal of Comparative Effectiveness Research Yes 1.906 16 2012 Nanomedicine Yes 5.005 24 2006 Neurodegenerative Disease Management Yes n/a 6 2011 Pain Management Yes n/a 6 2011 Personalized Medicine Yes 1.032 6 2004 Pharmacogenomics Yes 2.302 18 2000 Regenerative Medicine Yes 2.992 12 2006 PMC: PubMed Central. 3 SectionFuture Science Header and Newlands Press At-A-GlanceFuture Science FUTURE SCIENCE AND NEWLANDS PRESS AT-A-GLANCE Journal MEDLINE- Impact factor Frequency Launch indexed (2017) year Bioanalysis Yes 2.478 24 2009 BioTechniques Yes 2.098 12 1983 Future Medicinal Chemistry Yes 3.969 24 2009 Future Science OA PMC-indexed n/a Rolling 2015 International Journal of Pharmacokinetics No n/a 4 2016 Pharmaceutical Patent Analyst Yes n/a 6 2012 Therapeutic Delivery Yes n/a 12 2010 : Open access; PMC: PubMed Central. EBOOK COLLECTIONS We offer DRM-free perpetual access to a wide variety of eBook collections. 55 35 15 ONCOLOGY NEUROLOGY BIOMEDICINE 31 153 51 IMMUNOLOGY 15 CLINICAL DRUG R&D & INFECTIOUS CARDIOLOGY MEDICINE DISEASE 4 For more information visit www.future-science-group.com New to Future Science BIOTECHNIQUES ISSN (PRINT): 0736-6205 ISSN (ONLINE): 1940-9818 FREQUENCY: 12 issues per year IMPACT FACTOR: 2.098 (2017) BioTechniques is a MEDLINE-indexed, peer-reviewed, open access journal that provides the life science research community with an invaluable resource to access the latest methods, techniques and protocols. COVERAGE INCLUDES: • Bioengineering & Biophysics • Forensics • Cell Culture • Genetics & Genomics • Computational Biology • Microbiology • Drug Discovery & Development • Microscopy & Imaging • Epigenomics • Plant Biology • Protein Analysis 5 Information for Librarians INSTITUTIONAL & ACADEMIC SUBSCRIPTIONS Academic pricing is set regardless of size or number of sites. All academic institutions receive 5 years of content. For a quote, contact [email protected]. CORPORATE Corporate pricing is set depending on the size of the company and the number of sites. Corporate institutions receive 2 years of content (backfiles of content are available on request). CONSORTIA FSG works with consortia of various types and sizes, and welcomes discussion with all consortium managers. COUNTER-compliant usage statistics are provided for each institution. The benefits for the consortium include discounts on list price. Members have the flexibility to select the publications they want to include, or FSG will work with the consortium to create customized packages. INDEXING FSG titles are abstracted and indexed in all the main databases including MEDLINE/ Index Medicus, EMBASE/Excerpta Medica, Scopus, Clarivate’s Science Citation Index Expanded and Emerging Sources Citation Index, DOAJ, PubMed Central and Chemical Abstracts. 6 For more information visit www.future-science-group.com Institutional Trials Institutional Trials INSTITUTIONAL TRIALS If you would like to trial our content, simply get in touch at: [email protected]. Trials can be to single publications or entire collections; the choice is yours. We will work with you to decide on the best time and duration for your institution. DURING THE PERIOD, YOU HAVE: • Full-text access to the titles you select • Detailed usage statistics from our Atypon-backed platform • Support from our in-house technical team • Control over the duration, visibility and promotion of the trial Fair usage limits apply. For more details speak to a member of our team. SERVICES • Flexible purchasing • Accessible for all institution types • COUNTER-compliant usage reports • ATHENS & Shibboleth authentication compliant • Reliable publishing platform • Dynamic customer services • Promotion tools on request • Collection leasing 7 Digital Hubs DIGITAL HUBS In addition to our journal content, FSG publishes seven digital hubs, which enable professionals to easily connect and collaborate with their peers in niche scientific fields. Enriched with high-value expert insight and integration with social media, our hubs provide a route to further broadcast content published in our associated publications. 3DMedNet Infectious Diseases Hub Covering 3D printing and bioprinting in Covering all aspects of medical medicine and healthcare microbiology, from bench to bedside www.3dmednet.com www.id-hub.com Neuro Central Uniting all aspects of neurology and Bioanalysis Zone neuroscience Market-leading online resource for the www.neuro-central.com global bioanalytical community www.bioanalysis-zone.com Oncology Central Delivering the latest news and insights in the fast-moving field of oncology www.oncology-central.com BioTechniques The latest methods, techniques and protocols for the life science research RegMedNet community The latest research on all regenerative www.biotechniques.com medicine topics from stem cells to regenerative pharmaceuticals www.regmednet.com 8 For more information visit www.future-science-group.com Sponsorship Opportunities Header and Testimonials SPONSORSHIP OPPORTUNITIES Each of our digital hubs offers a variety of sponsorship opportunities, which include: • Expert interviews and reviews • Infographics • Online symposia • Spotlights
Recommended publications
  • Future Science Group
    future science group CATALOGUE 2014 www.future-science-group.com Contents Welcome 2 International Journal of Future Science Subject collections 4 Endocrine Oncology 30 Journals 43 Future Medicine International Journal of Bioanalysis 46 Hematologic Oncology 31 Journals 11 Clinical Investigation 47 Interventional Biomarkers in Medicine 14 Future Medicinal Chemistry 48 Cardiology 32 Breast Cancer Management 15 Pharmaceutical Journal of Comparative Clinical Lipidology 16 Bioprocessing 49 Effectiveness Research 33 Clinical Practice 17 Pharmaceutical Patent Lung Cancer Analyst 50 CNS Oncology 18 Management 34 Therapeutic Delivery 51 Colorectal Cancer 19 Melanoma eBooks Diabetes Management 20 Management 35 52 Publication Epigenomics 21 Nanomedicine 36 solutions 56 Future Cardiology 22 Neurodegenerative Post-publication Future Microbiology 23 Disease Management 37 solutions 58 Future Neurology 24 Pain Management 38 Information for Future Oncology 25 Personalized Medicine 39 authors 59 Future Virology 26 Pharmacogenomics 40 Information for Hepatic Oncology 27 Regenerative Medicine 41 librarians 60 Immunotherapy 28 Women’s Health 42 Trials information 61 International Journal of Clinical Rheumatology 29 Future Science Group – Catalogue 2014 Browse our products & services Subject collections 4–9 “Your Complete Digital Library” To help you pinpoint the most relevant titles for you, we have highlighted journals that fall within one of our subject collections: Oncology, Neurology, Cardiology, Immunology, Molecular Medicine and Drug R&D. Look for the subject collection tab on each journal page. Future Medicine Journals 11–42 “Tomorrow’s medicine today” 30 journals providing cutting-edge coverage of postgenomic medicine. Future Science Journals 43–51 “Revelations in R&D” High-quality commentary and analysis in today’s key areas of research endeavor.
    [Show full text]
  • 28 Practical Dermatology March 2008
    he influence of “the literature” on daily medical ings from a Merck-sponsored study of rofecoxib, alleging that practice is incalculable. Through it, researchers manuscript authors suppressed evidence of cardiac effects caused share and pursue additional avenues of discovery, by the medication. Certainly peer reviewers can assess the infor- while clinicians uncover the latest information mation presented in a publication, but they cannot know what about new patient care strategies. Without pub- relevant information is not presented. Tlished studies documenting the efficacy of new drugs, physicians According to the International Committee of Medical would be hard-pressed to adopt them into practice. Every clini- Journal Editors (ICMJE), a peer-reviewed journal is “one that cian has at some point mined the literature for clues to the diag- submits most of its published research articles for outside nosis or management of a challenging case. The literature can review.” The group of general medical journal editors whose par- even influence insurance coverage decisions, as companies deter- ticipants meet annually and produce the Uniform Requirements mine broad policies and decide case-by-case coverage based on for Manuscripts (URM), acknowledges that, “The number and available published evidence. kind of manuscripts sent for review, the number of reviewers, the It is incumbent upon physicians to keep abreast of the litera- reviewing procedures, and the use made of the reviewers’ opin- ture relevant to their field of practice. Yet familiarity with med- ions may vary. In the interests of transparency, each journal ical journals may breed complacency; those who depend on should publicly disclose its policies in its instructions to these publications may take for granted the quality of informa- authors.” Among US journals, both the Journal of the American tion presented in the canon of the literature while unduly dis- Academy of Dermatology and Archives of Dermatology follow the missing other worthy sources of pertinent, quality information.
    [Show full text]
  • PATHOLOGY, Faculty of Medicine, Institute of Medical Sciences A
    FORMAT FOR SUBJECTWISE IDENTIFYING JOURNALS BY THE UNIVERSITIES AND APPROVAL OF THE UGC {Under Clause 6.05 (1) of the University Grants Commission (Minimum Qualifications for appointment of Teacher and Other Academic Staff in Universities and Colleges and Measures for the Maintenance of Standards in Higher Education (4th Amendment), Regulations, 2016} Subject: PATHOLOGY, Faculty of Medicine, Institute of Medical Sciences A. Refereed Journals Sl. Name of the Journal Publisher and Year of Hard e-publication ISSN Number Peer / Indexing status. Impact Do you use Any other No. place of Start copies (Yes/No) Refree If indexed, Factor/Rating. any Information publication published Reviewed Name of the Name of the IF exclusion (Yes/No) (Yes/No) indexing data assigning agency. criteria for base Whether covered Research by Thompson & Journals Reuter (Yes/No) 1 2 3 4 5 6 7 8 9 10 11 1 Acta cytologica Karger, Basel 1957 Yes Yes 0001-5547(Print); Yes Indexed (Index 1.562 (Impact (Switzerland) 1938- medicus, Medline, Factor by Thomson 2650(Electronic); Pubmed) Reuters) 0001-5547(Linking) 2 Acta oncologica Informa Healthcare, 1987 No Yes 0284-186X(Print); Yes Indexed (Index 3.730 (Impact London (England) 1651- medicus, Medline, Factor by Thomson 226X(Electronic); Pubmed) Reuters) 0284-186X(Linking) 3 Advances in anatomic pathology Lippincott Williams 1994 Yes Yes 1072-4109(Print); Yes Indexed (Index 2.919 (Impact & Wilkins, 1533- medicus, Medline, Factor by Thomson Hagerstown, MD 4031(Electronic); Pubmed) Reuters) 1072-4109(Linking) 4 American journal of clinical oncology Lippincott Williams 1982 Yes Yes 0277-3732(Print); Yes Indexed (Index 2.977 (Impact & Wilkins, 1537- medicus, Medline, Factor by Thomson Hagerstown, MD 453X(Electronic); Pubmed) Reuters) 0277-3732(Linking) Sl.
    [Show full text]
  • Using Pubmed …For Searching the MEDLINE Database
    UUssiinngg PPuubbMMeedd …for searching the MEDLINE database Available online at http://pubmed.gov A condensed version of the National Training Center and Clearinghouse’s NLM Training: PubMed Compiled by New England Region of the National Network of Libraries of Medicine University of Massachusetts Medical School Worcester, MA Reprints: Phone 800-338-7657 July 2004 Searching MEDLINE PubMed Pubmed.gov 1 Searching MEDLINE PubMed TABLE OF CONTENTS PUBLISHER SUPPLIED CITATIONS ....................................................................................................................4 IN PROCESS CITATIONS........................................................................................................................................5 OTHER PUBLISHER SUPPLIED CITATIONS.....................................................................................................5 MEDLINE & MEDLINE CITATIONS ....................................................................................................................5 OLDMEDLINE CITATIONS ....................................................................................................................................6 PUBMED SIDEBAR ...................................................................................................................................................7 SEARCHING WITH PUBMED ................................................................................................................................8 WHAT IS SEARCHED?.............................................................................................................................................8
    [Show full text]
  • Some Thoughts on Writing and Reviewing Scientific Articles
    Elsevier-sponsored workshop held at the 25th Congress of the International Society of Forensic Genetics (ISFG) Scientific Publication: Reading, Writing, and Reviewing John M. Butler, PhD U.S. National Institute of Standards and Technology (NIST) Associate Editor, Forensic Science International: Genetics Melbourne, Australia 5 September 2013 Presentation Outline The 3 R’s of Scientific Publication: Reading, (Re-)Writing, and Reviewing • Introduction • Reading – Tools for reference collection • Writing – Submission & peer-review process • Reviewing • FSI Genetics Target Audience for This Presentation • Young (or even more seasoned) scientists who want to learn how to write better or become a more effective reviewer • Anyone who wants to better understand the review process “Writing a manuscript is arguably the single most critical component to being a scientist – one for which, in many cases, formal training is minimal.” - Dr. Nathan Blow, BioTechniques editor-in-chief (May 2013, p. 235) My Qualifications on this Topic • Degrees in chemistry – BYU (B.S., 1992), University of Virginia (Ph.D., 1995) – Undergraduate classes on scientific writing and public speaking • Research-focused career E – Published ~150 articles and invited book chapters x – Given >300 presentations on scientific topics p e • Love for teaching r – Written four books (so far) on forensic DNA typing i e • Active reviewer and journal editor responsibilities n – Associate editor of Forensic Science International: Genetics since 2007 c – Reviewed hundreds of articles for
    [Show full text]
  • MICROBIOLOGY, Faculty of Medicine, Institute of Medical Sciences A
    FORMAT FOR SUBJECTWISE IDENTIFYING JOURNALS BY THE UNIVERSITIES AND APPROVAL OF THE UGC {Under Clause 6.05 (1) of the University Grants Commission (Minimum Qualifications for appointment of Teacher and Other Academic Staff in Universities and Colleges and Measures for the Maintenance of Standards in Higher Education (4th Amendment), Regulations, 2016} Subject: MICROBIOLOGY, Faculty of Medicine, Institute of Medical Sciences A. Refereed Journals Sl. Name of the Journal Publisher and Year of Hard e-publication ISSN Number Peer / Indexing status. Impact Do you use Any other No. place of Start copies (Yes/No) Refree If indexed, Factor/Rating. any Information publication published Reviewed Name of the Name of the IF exclusion (Yes/No) (Yes/No) indexing data assigning agency. criteria for base Whether covered Research by Thompson & Journals Reuter (Yes/No) 1 2 3 4 5 6 7 8 9 10 11 1 J MOL MICROB BIOTECH, Journal of Basel ; New York : Karger, 1999 Yes e-ISSN: 1660- 1464-1801 Yes Index medicus: 1.701 /Thomson molecular microbiology and biotechnology Switzerland 2412 v1n1,Aug. 1999-; Reuter- Y MEDLINE: v1n1; Aug. 1999-PubMed: v1n1,Aug. 1999- 2 LETT APPL MICROBIOL, Letters in applied Oxford, UK : Published for 1985 Yes Online ISSN: 0266-8254 Yes Index medicus: 1.579/ N microbiology the Society for Applied 1472-765X v26n4,Apr. 1998-; Bacteriology by Blackwell MEDLINE: v26n4,Apr. Scientific Publications, 1998-; PubMed: England v26n4,Apr. 1998- 3 MED MICROBIOL IMMUN, Medical Berlin, New York, 1971 Yes 1432-1831 0300-8584 Yes Index medicus: v157n1, 2.302/ N microbiology and immunology Springer-Verlag, (Electronic) 1971-; MEDLINE: GERMANY v157n1, 1971-; PubMed: v157n1, 1971- 4 METHOD MICROBIOL, Methods in Troy Mo : Academic 1969 Yes 0580-9517 Yes microbiology Press, UNITED STATES 5 MICROB DRUG RESIST, Microbial drug Larchmont, N.Y.
    [Show full text]
  • De Novo Transcriptome Sequencing and Gene Expression Profiling With/Without B-Chromosome Plants of Lilium Amabile Doori Park, Jong-Hwa Kim, Nam-Soo Kim
    www.genominfo.org eISSN 2234-0742 Volume 17 number 3, September 30, 2019 Aims and scope Genomics & Informatics is the official journal of the Korea Genome Organization (http://kogo.or.kr). Its abbreviated title is Genomics Inform. It was launched in 2003 by the Korea Genome Organization. It aims at making a substantial contribution to the understanding of any areas of genomics or informatics. Its scope includes novel data on the topics of gene discovery, comparative genome analyses, molecular and human evolution, informatics, genome structure and function, technological innovations and applications, statistical and mathematical methods, cutting-edge genetic and physical mapping, next generation sequencing and de novo assembly, and other topics that present data where sequence information is used to address biological concerns. Especially, Clinical genomics section is for a short report of all kinds of genome analysis data from clinical field such as cancer, diverse complex diseases and genetic diseases. It encourages submission of the cancer panel analysis data for a single cancer patient or a group of patients. It also encourages deposition of the genome data into designated database. Genome archives section is for a short manuscript announcing the genetic information of recently sequenced prokaryotic and eukaryotic genomes. These genome archives data can make the rationale for sequencing a specific organism. It is published and distributed quarterly at the last dates of March, June, September, and December. All submitted manuscripts will be reviewed and selected for publication after single blind review process. All manuscripts must be submitted online through the e-submission system available from: http://submit.genominfo.org.
    [Show full text]
  • Microbiology Society
    MICROBIOLOGY TODAY 47:1 May 2020 Microbiology Today May 2020 47:1 Why Microbiology Matters – 75th anniversary issue Why Microbiology Matters We are celebrating our 75th anniversary by showcasing why microbiology matters and the impact of microbiologists past, present and future. MICROBIOLOGY TODAY 47:1 May 2020 Microbiology Today May 2020 47:1 Why Microbiology Matters – 75th anniversary issue Why Microbiology Matters We are celebrating our 75th anniversary by showcasing why microbiology matters and the impact of microbiologists past, present and future. Editorial Welcome to Microbiology Today, which has a new look. This issue is the first of two special editions of the magazine to be published in the 75th anniversary year of the Microbiology Society. As we look back and celebrate during 2020, we are also considering ‘Why Microbiology Matters’. The longer you think about it, the more you realise how in so many ways it does. Whole Picture ince the first observations of microbes by Antonie van thrive in extreme conditions and are found in every niche Leeuwenhoek in the 1600s, our understanding of how around the globe. Smicrobes underpin and impact our lives has advanced Part of the reason for the success of microbes in these considerably. From discovering their life cycles and roles within varied environments is their genetic plasticity. Charles Dorman various environmental niches to harnessing them in industrial introduces the next section on microbial genetics and the role processes, and, not least, our ability to utilise them for good, to it has played in advancing modern biotechnology. From the vaccinate and treat diseases, with many diseases now known original discovery of restriction enzymes through to potential to be caused by microbes.
    [Show full text]
  • Biosafety and Health
    BIOSAFETY AND HEALTH AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.6 ISSN: 2590-0536 DESCRIPTION . Biosafety and Health is an open access, peer-reviewed journal sponsored by the Chinese Medical Association, managed by National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC). This journal aims to publish original research findings and thoughts in any aspect connected with public health and biosafety. Topics include but are not limited to: Identification and characterization of biological threats; Origin, transmission, and evolution of biological agents; Surveillance, risk assessment, and early-warning; Prevention, diagnosis, and therapeutics; Synthetic biotechnology, genome editing, and other new biotechniques; Biosafety materials; Policies and standards. Biosafety and Health is published bimonthly in English language. Article types include Original Research, Reviews, Perspectives, Correspondence, Case Report, News and Views, Highlights, Comments and policy forum, etc. ABSTRACTING AND INDEXING . Directory of Open Access Journals (DOAJ) Scopus EDITORIAL BOARD . Editor-in-Chief Guizhen Wu, National Institute for Viral Disease Control and Prevention, Beijing, China Research on the prevention and control of infectious diseases, in addiiton to the treatment and traceability of major emergency infectious diseases, Research on the management of laboratory biosafety. Executive Editor-in-Chief
    [Show full text]
  • Pubmed: the Bibliographic Database Kathi Canese and Sarah Weis Created: October 9, 2002; Updated: March 20, 2013
    13 PubMed: The Bibliographic Database Kathi Canese and Sarah Weis Created: October 9, 2002; Updated: March 20, 2013. Summary PubMed is a free resource developed and maintained by the National Center for Biotechnology Information (NCBI), a division of the U.S. National Library of Medicine (NLM), at the National Institutes of Health (NIH). PubMed comprises over 22 million citations and abstracts for biomedical literature indexed in NLM’s MEDLINE database, as well as from other life science journals and online books. PubMed citations and abstracts include the fields of biomedicine and health, and cover portions of the life sciences, behavioral sciences, chemical sciences, and bioengineering. PubMed also provides access to additional relevant websites and links to other NCBI resources, including its various molecular biology databases. PubMed uses NCBI's Entrez search and retrieval system. PubMed does not include the full text of the journal article; however, the abstract display of PubMed citations may provide links to the full text from other sources, such as directly from a publisher’s website or PubMed Central (PMC). Data Sources MEDLINE The primary component of PubMed is MEDLINE, NLM’s premier bibliographic database, which contains over 19 million references to journal articles in life sciences, with a concentration on biomedicine. The majority of journals selected for MEDLINE are based on the recommendation of the Literature Selection Technical Review Committee (LSTRC), an NIH-chartered advisory committee of external experts analogous to the committees that review NIH grant applications. Some additional journals and newsletters are selected based on NLM- initiated reviews in areas that are special priorities for NLM or other NIH components (e.g., history of medicine, health services research, AIDS, toxicology and environmental health, molecular biology, and complementary medicine).
    [Show full text]
  • Future Science Group Catalogue 2020
    Header Future Science Group Catalogue 2020 1 Section Header 2 For more information visit www.future-science-group.com Contents Page Our Journal Portfolio 2 ........................................................................................................................................ Future Medicine At-A-Glance 3 ........................................................................................................................................ Future Science and Newlands Press At-A-Glance 4 ........................................................................................................................................ eBook Collections 4 ........................................................................................................................................ New to Future Science Group 5 ........................................................................................................................................ Information for Librarians 6 ........................................................................................................................................ Institutional Trials 7 ........................................................................................................................................ Digital Hubs 8 ........................................................................................................................................ Sponsorship Opportunities 9 .......................................................................................................................................
    [Show full text]
  • Future Science Group – Catalogue 2013 Expert Review of Anti‑Infective Therapy
    future science group Catalogue 2013 www.future-science-group.com What are you looking for? The Expert Review Series 4–25 Subject collections 71–75 “Your essential medical review collection” “Your Complete Digital Library” 18 journals covering all aspects of To help you pinpoint the most relevant modern medicine. titles for you, we have highlighted journals that fall within one of our subject collections: Oncology, Cardiology, Immunology, Neurology Future Medicine Journals 26–58 and Environmental. Look for the subject collection tab on each journal page. “Tomorrow’s medicine today” 29 journals providing cutting-edge coverage of postgenomic medicine. Our eBooks 76–77 Future Science Journals 60–70 “Your essential resources for “Revelations in R&D” scientific research” High-quality commentary and analysis in Over 100 eBooks written by some of the today’s key areas of research endeavor. world’s leading experts covering the most important and emerging areas in medicine today. Contents Full contents The Expert Review Series Future Neurology 41 Expert Review of Anticancer Therapy 8 Future Oncology 42 Expert Review of Anti-infective Therapy 9 Future Virology 43 Expert Review of Cardiovascular Therapy 10 Imaging in Medicine 44 Expert Review of Clinical Immunology 11 Immunotherapy 45 Expert Review of Clinical Pharmacology 12 International Journal of Hematologic Oncology 46 Expert Review of Dermatology 13 International Journal of Clinical Rheumatology 47 Expert Review of Endocrinology & Metabolism 14 Interventional Cardiology 48 Expert Review of Gastroenterology
    [Show full text]